RxDoctor Payments Data

Folashade Afolabi

Pediatric Pulmonology · Dallas, TXNPI 1619140100

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations.

$2,867in general payments, 2019–2025

Across 114 payments — averaging $25.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$667
  • Baxter Healthcare$426
  • Chiesi USA, Inc.$337
  • AstraZeneca$262
  • Vertex$187
  • Aimmune Therapeutics, Inc.$141
  • plus $847 from 15 others

What the payments were for

  • Food & beverage$2,853100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,867 in reported general payments places this provider in the 75th percentile of 104 pediatric pulmonology providers in Texas.

See all pediatric pulmonology providers in Texas

Other pediatric pulmonology in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →